Perinatal outcome in pregnant women with cancer: are there any effects of chemotherapy?
暂无分享,去创建一个
A. Lanzone | G. Capelli | S. Ferrazzani | S. Garofalo | S. De Carolis | M. D. De Carolis | S. Salvi | V. Degennaro
[1] S. Oh,et al. Clinical characteristics and outcome of cancer diagnosed during pregnancy , 2016, Obstetrics & gynecology science.
[2] O. Paltiel,et al. Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. , 2016, The New England journal of medicine.
[3] S. Caritis,et al. Pharmacokinetics of drugs in pregnancy. , 2015, Seminars in perinatology.
[4] Otto W. Witte,et al. Role of catecholamines in maternal-fetal stress transfer in sheep. , 2015, American journal of obstetrics and gynecology.
[5] T. Cotechini,et al. Aberrant maternal inflammation as a cause of pregnancy complications: A potential therapeutic target? , 2015, Placenta.
[6] G. Scambia,et al. Placental and infant metastasis of maternal melanoma: A new case , 2015, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[7] K. Roszkowski,et al. Cancer treatment in pregnant women , 2014, Contemporary oncology.
[8] G. Hortobagyi,et al. Outcomes of children exposed in utero to chemotherapy for breast cancer , 2014, Breast Cancer Research.
[9] O. Mir,et al. Gynecologic Cancers in Pregnancy: Guidelines of a Second International Consensus Meeting , 2009, International Journal of Gynecologic Cancer.
[10] N. Colombo,et al. Are monoclonal antibodies a safe treatment for cancer during pregnancy? , 2013, Immunotherapy.
[11] A. Avilés,et al. Hematological malignancies and pregnancy: Treat or no treat during first trimester , 2012, International journal of cancer.
[12] R. Somer,et al. Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] B. Franke,et al. Aetiology of hypospadias: a systematic review of genes and environment. , 2012, Human reproduction update.
[14] M. El-Bayoumi,et al. Cancer during pregnancy: perinatal outcome after in utero exposure to chemotherapy , 2012, Archives of Gynecology and Obstetrics.
[15] L. Lagae,et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. , 2012, The Lancet. Oncology.
[16] M. Dimopoulos,et al. Trastuzumab administration during pregnancy: a systematic review and meta-analysis , 2012, Breast Cancer Research and Treatment.
[17] M. Freemark,et al. Placental hormones and the control of maternal metabolism and fetal growth , 2011, Current opinion in endocrinology, diabetes, and obesity.
[18] L. Lagae,et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. , 2010, European journal of cancer.
[19] J. Beijnen,et al. Transplacental Transfer of Paclitaxel, Docetaxel, Carboplatin, and Trastuzumab in a Baboon Model , 2010, International Journal of Gynecologic Cancer.
[20] K. Chun,et al. Neoadjuvant chemotherapy with paclitaxel plus platinum followed by radical surgery in early cervical cancer during pregnancy: three case reports. , 2010, Japanese journal of clinical oncology.
[21] N. Pavlidis,et al. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors. , 2010, Cancer treatment reviews.
[22] E. Cardonick,et al. Perinatal Outcomes of a Pregnancy Complicated by Cancer, Including Neonatal Follow-Up After in Utero Exposure to Chemotherapy: Results of an International Registry , 2009, American journal of clinical oncology.
[23] N. Pavlidis,et al. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors. , 2010, Cancer treatment reviews.
[24] P. Kyle,et al. Aetiology and pathogenesis of IUGR. , 2009, Best practice & research. Clinical obstetrics & gynaecology.
[25] A. Goldhirsch,et al. Weekly epirubicin in the treatment of gestational breast cancer (GBC) , 2009, Breast Cancer Research and Treatment.
[26] G. Hortobagyi,et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero , 2006, Cancer.
[27] A. Caruso,et al. Cancer in pregnancy: results of a series of 32 patients. , 2006, Anticancer research.
[28] Roisin Ní Mhuireachtaigh,et al. Anesthesia in pregnant patients for nonobstetric surgery. , 2006, Journal of clinical anesthesia.
[29] N. Pavlidis,et al. Cancer and pregnancy: poena magna, not anymore. , 2006, European journal of cancer.
[30] M. Lishner,et al. Impact and treatment of cancer during pregnancy , 2004, Expert review of anticancer therapy.
[31] E. Cardonick,et al. Use of chemotherapy during human pregnancy. , 2004, The Lancet. Oncology.
[32] F. Goldwasser,et al. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[33] M. D. De Santis,et al. Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel. , 2000, European journal of cancer care.
[34] T. Lallas,et al. Chemotherapy in pregnancy. , 1998, Obstetrics and gynecology clinics of North America.
[35] W. Kirch,et al. Cytotoxic therapy and pregnancy. , 1997, Pharmacology & therapeutics.
[36] G. Koren,et al. Cancer in Pregnancy: Maternal and Fetal Risks: Maternal and fetal outcome following Hodgkin's disease in pregnancy , 1996 .
[37] G. Koren,et al. Fetal outcome after in utero exposure to cancer chemotherapy. , 1992, Archives of internal medicine.
[38] Caligiuri Ma,et al. Pregnancy and leukemia. , 1989 .
[39] M. Caligiuri,et al. Pregnancy and leukemia. , 1989, Seminars in oncology.
[40] Q. S. Ringenberg,et al. Management of cancer during pregnancy. , 1988, Archives of internal medicine.
[41] J. Turchi,et al. Anthracyclines in the treatment of malignancy in pregnancy , 1988, Cancer.
[42] A. Wilkinson,et al. New birthweight and head circumference centiles for gestational ages 24 to 42 weeks. , 1987, Early human development.
[43] N. Greer,et al. Fetal Risk of Anesthesia and Surgery during Pregnancy , 1986, Anesthesiology.